Literature DB >> 33219395

Control of immunity by glucocorticoids in health and disease.

Akihiro Shimba1,2, Koichi Ikuta3.   

Abstract

Animals receive environmental stimuli from neural signals in order to produce hormones that control immune responses. Glucocorticoids (GCs) are a group of steroid hormones produced in the adrenal cortex and well-known mediators for the nervous and immune systems. GC secretion is induced by circadian rhythm and stress, and plasma GC levels are high at the active phase of animals and under stress condition. Clinically, GCs are used for allergies, autoimmunity, and chronic inflammation, because they have strong anti-inflammatory effects and induce the apoptosis of lymphocytes. Glucocorticoid receptor (GR) acts as a transcription factor and represses the expression of inflammatory cytokines, chemokines, and prostaglandins by binding to its motif, glucocorticoid-response element, or to other transcription factors. In mice, GR suppresses the antigen-stimulated inflammation mediated by macrophages, dendritic cells, and epithelial cells, and impairs cytotoxic immune responses by downregulating interferon-γ production and inhibiting the development of type-1 helper T cells, CD8+ T cells, and natural killer cells. These immune inhibitory effects prevent lethality by excessive inflammation, but at the same time increase the susceptibility to infection and cancer. GCs can also activate the immune system. The circadian cycle of GC secretion controls the diurnal oscillations of the distribution and response of T cells, thus supporting T cell maintenance and effective immune protection against infection. Moreover, several reports have shown that GR has the potential to enhance the activities of Th2, Th17, and immunoglobulin-producing B cells. Stress has two different effects on immune responses: immune suppression to cause mortality by infection and cancer, and excessive immune activation to induce chronic inflammation and autoimmune disease. Consistently, stress-induced GCs strongly suppress cell-mediated immunity and cause viral infection and tumor development. They may also enhance the development of pathogenic helper T cells and cause tissue damage through neural and intestinal inflammation. Past studies have reported the positive and negative effects of GCs on the immune system. These opposing properties of GCs may regulate the immune balance between the responsiveness to antigens and excessive inflammation in steady-state and stress conditions.

Entities:  

Keywords:  CXCR4; Cell-mediated immunity; Circadian rhythm; Glucocorticoid; Glucocorticoid receptor; IL-7R; Stress; Th17 cell; Th2 cell

Mesh:

Substances:

Year:  2020        PMID: 33219395     DOI: 10.1007/s00281-020-00827-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  16 in total

1.  Fear of cancer recurrence is related to the efficacy of immunotherapy and quality of life in patients with NSCLC during the COVID-19 pandemic in China.

Authors:  Xiangxiang Yin; Yuhang Cheng; Senbang Yao; Junxu Wu; Shaochun Liu; Wen Li; Sheng Yu; Lingxue Tang; Yanyan Jing; Lulian Pang; Huaidong Cheng
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Low Serum Calcium Concentration in Patients With Systemic Lupus Erythematosus Accompanied by the Enhanced Peripheral Cellular Immunity.

Authors:  Xue Du; Di Zhao; Ying Wang; Zhengyi Sun; Qiuyang Yu; Hongyu Jiang; Liying Wang
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

3.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

4.  Optogenetic modulation of electroacupuncture analgesia in a mouse inflammatory pain model.

Authors:  I-Han Hsiao; Hsien-Yin Liao; Yi-Wen Lin
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

Review 5.  Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Chiara Di Pentima; Piero Giordano; Andrea Giacometti
Journal:  Intern Emerg Med       Date:  2021-10-31       Impact factor: 3.397

6.  A new experimental design to study inflammation-related versus non-inflammation-related depression in mice.

Authors:  Pierre Cardinal; Camille Monchaux de Oliveira; Nathalie Castanon; Lucile Capuron; Julie Sauvant; Aline Foury; Muriel Darnaudéry; Sylvie Vancassel
Journal:  J Neuroinflammation       Date:  2021-12-11       Impact factor: 8.322

Review 7.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

Review 8.  Programming of Vascular Dysfunction by Maternal Stress: Immune System Implications.

Authors:  Tiago J Costa; Júlio Cezar De Oliveira; Fernanda Regina Giachini; Victor Vitorino Lima; Rita C Tostes; Gisele Facholi Bomfim
Journal:  Front Physiol       Date:  2022-03-10       Impact factor: 4.566

Review 9.  Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.

Authors:  Remo Poto; Teresa Troiani; Gjada Criscuolo; Giancarlo Marone; Fortunato Ciardiello; Carlo Gabriele Tocchetti; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 10.  Intestinal Homeostasis under Stress Siege.

Authors:  Fabiola Guzmán-Mejía; Marycarmen Godínez-Victoria; Alan Vega-Bautista; Judith Pacheco-Yépez; Maria Elisa Drago-Serrano
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.